Drug combination might offer hope for patients with deadly brain tumors
Publication year - 2007
Publication title -
cancer biology and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.166
H-Index - 113
eISSN - 1555-8576
pISSN - 1538-4047
DOI - 10.4161/cbt.6.11.5504
Subject(s) - bevacizumab , medicine , irinotecan , regimen , brain tumor , oncology , chemotherapy , cancer , chemotherapy regimen , pathology , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom